Companies / Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc.

Nasdaq: RANICIK 1856725SAN JOSE, CA

Financials · FY2025

Revenue$1.63M
Net income$-40.95M
Total debt$0
Cash$4.87M
Diluted EPS$-0.45
Shares outstanding123.9M

Ownership

123.9M shares outstanding · as of Apr 30, 2026
13.0%10%+ / strategic
Ownership
80.7%Class A
Share classes
Class A80.65%
Class B19.35%
10%+ / strategic12.95%16,045,343
Institutions26.12%32,358,533
Public float60.93%75,478,998

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Imran Mir aDirector · 10% owner
Javadi AlirezaChief Technical Officer

Institutional holders 68

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 28, 2026Ausiello Dennis A
Director
GrantDirector Stock Option (Right to Buy)+124K
123,600
0.10% of shares
low
May 28, 2026Butel Jean Luc
Director
GrantDirector Stock Option (Right to Buy)+124K
123,600
0.10% of shares
low
May 28, 2026Imran Mir a
Director
GrantDirector Stock Option (Right to Buy)+124K
123,600
0.10% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Vanguard Group IncPassive13G5,109,368
AWM Investment Company, Inc.Passive13G9,745,343
SymBiosis Capital Partners, LLCPassive13G6,300,000

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RANI753018100